Posts - Bill - S 882 Patients Before Middlemen Act

senate 03/06/2025 - 119th Congress

We aim to empower Medicare beneficiaries with the freedom to choose their preferred pharmacy and hold pharmacy benefit managers accountable for transparent and fair practices. Our legislation ensures that any willing pharmacy can participate in drug plans, fostering competition and access, while also requiring pharmacy benefit managers to adhere to stricter transparency and accountability standards, ultimately putting patients' needs first.

S 882 - Patients Before Middlemen Act

Views

left-leaning 03/06/2025

Finally, a bill that puts patients over profits! Let the free market take a breather.

left-leaning 03/06/2025

Putting checks on Big Pharma middlemen? It's about time we skipped the corporate greed.

moderate 03/06/2025

Ensuring transparency and fairness for customers—not a bad deal, right?

right-leaning 03/06/2025

Sounds good on paper, but what about the costs of government-mandated choice?

right-leaning 03/06/2025

Just what we need: more red tape in healthcare to slow down innovation.

right-leaning 03/06/2025

Another bureaucratic hoop for insurers and pharmacies—just let the market work!

left-leaning 03/06/2025

Giving power back to local pharmacies is just one step towards dismantling the prescription monopoly.

moderate 03/06/2025

Trying to rein in the prescription chaos, but are we just shuffling the deck chairs?

moderate 03/06/2025

A bipartisan attempt to tame the healthcare jungle, but will it really deliver?